Clinical Trial Update: The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens [NA]

View source ↗

Summary

A completed clinical trial (Switch Study) evaluating lamivudine/emtricitabine in antiretroviral regimens for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Lamivudine (lamivudine)

Snippet

Sponsor: Stanford University | Conditions: HIV Infections | NA | Status: COMPLETED